| # | Title | Journal | Year | Citations |
|---|
| 1 | Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study | Lancet Respiratory Medicine,the | 2022 | 74 |
| 2 | Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program | Advances in Therapy | 2020 | 66 |
| 3 | Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes | Diabetes, Obesity and Metabolism | 2020 | 53 |
| 4 | Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab | Drug Safety | 2020 | 47 |
| 5 | Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab | Advances in Therapy | 2022 | 47 |
| 6 | NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma | Respiratory Research | 2020 | 45 |
| 7 | Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort | European Respiratory Journal | 2021 | 43 |
| 8 | The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis | Rheumatology | 2021 | 42 |
| 9 | Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis | BMJ Open | 2020 | 41 |
| 10 | Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT‐2 study): 52‐week results from a randomized controlled trial | Diabetes, Obesity and Metabolism | 2020 | 38 |
| 11 | Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis | RMD Open | 2020 | 35 |
| 12 | Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review | Journal of Allergy and Clinical Immunology: in Practice | 2020 | 30 |
| 13 | Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments | Thorax | 2021 | 26 |
| 14 | Clinical and economic burden of severe asthma among US patients treated with biologic therapies | Annals of Allergy, Asthma and Immunology | 2021 | 25 |
| 15 | Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy | Journal of Allergy and Clinical Immunology: in Practice | 2021 | 23 |
| 16 | Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis | Seminars in Arthritis and Rheumatism | 2021 | 23 |
| 17 | Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma | JAMA Network Open | 2022 | 23 |
| 18 | Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care | Diabetes, Obesity and Metabolism | 2021 | 22 |
| 19 | Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies | Diabetes, Obesity and Metabolism | 2021 | 21 |
| 20 | The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization | Rheumatology and Therapy | 2021 | 21 |
| 21 | Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use | Journal of Allergy and Clinical Immunology: in Practice | 2022 | 21 |
| 22 | Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015 | Lupus Science and Medicine | 2021 | 20 |
| 23 | Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes | Kidney International Reports | 2020 | 19 |
| 24 | Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination | The Lancet Global Health | 2022 | 19 |
| 25 | Health-related quality of life 1–3 years post-myocardial infarction: its impact on prognosis | Open Heart | 2021 | 18 |
| 26 | How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies | CKJ: Clinical Kidney Journal | 2022 | 17 |
| 27 | A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease | Kidney International | 2022 | 17 |
| 28 | Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial | Science Translational Medicine | 2021 | 16 |
| 29 | Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis | Annals of Allergy, Asthma and Immunology | 2021 | 16 |
| 30 | Renal outcomes and all‐cause death associated with sodium‐glucose co‐transporter‐2 inhibitors versus other glucose‐lowering drugs (CVD‐REAL 3 Korea) | Diabetes, Obesity and Metabolism | 2021 | 15 |
| 31 | Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data | Cardiovascular Diabetology | 2021 | 15 |
| 32 | Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study | Rheumatology and Therapy | 2020 | 14 |
| 33 | Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study | Respiratory Medicine | 2022 | 14 |
| 34 | Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma | Thorax | 2023 | 14 |
| 35 | The relationship between airway immunoglobulin activity and eosinophils in COPD | Journal of Cellular and Molecular Medicine | 2021 | 13 |
| 36 | Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients | CKJ: Clinical Kidney Journal | 2021 | 13 |
| 37 | Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care | Journal of Asthma and Allergy | 2021 | 13 |
| 38 | Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study | Diabetes, Obesity and Metabolism | 2021 | 12 |
| 39 | Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015 | Lupus Science and Medicine | 2021 | 12 |
| 40 | Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials | Advances in Therapy | 2022 | 12 |
| 41 | Real-World Assessment of Asthma Specialist Visits Among U.S. Patients with Severe Asthma | Journal of Allergy and Clinical Immunology: in Practice | 2021 | 11 |
| 42 | The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme | European Respiratory Journal | 2022 | 11 |
| 43 | Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis | Rheumatology Advances in Practice | 2021 | 10 |
| 44 | Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma | Journal of Asthma and Allergy | 2021 | 10 |
| 45 | Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma | Annals of Allergy, Asthma and Immunology | 2021 | 10 |
| 46 | Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis | Rheumatology Advances in Practice | 2021 | 10 |
| 47 | Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals | BMC Medicine | 2022 | 10 |
| 48 | Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination | Clinical and Translational Immunology | 2022 | 10 |
| 49 | OP0049 EFFICACY OF ANIFROLUMAB IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: PATIENT SUBGROUP ANALYSIS OF BICLA RESPONSE IN 2 PHASE 3 TRIALS | Annals of the Rheumatic Diseases | 2020 | 9 |
| 50 | Mapping geographic variability of severe uncontrolled asthma in the United States | Annals of Allergy, Asthma and Immunology | 2022 | 9 |
